Guam Senators Plan to Discuss Four Anti-Smoking Bills

Regulations by 2FIRSTS.ai
Dec.12.2023
Guam Senators Plan to Discuss Four Anti-Smoking Bills
Guam senators plan to discuss four bills in a public hearing on Tuesday to curb teenage smoking.

According to a report by Guampdn, Guam senators are planning to discuss four bills in a public hearing on Tuesday, December 12, aimed at curbing teenage smoking on the island. The hearing will take place at 1:30 PM at the Guam Legislature Building. These bills have been proposed by Senator Sabina Perez.

 

Senator Perez highlighted the detrimental effects of tobacco and nicotine use and dependence, particularly on adolescents who are still in the developmental stage. According to a report from the State Epidemiological Outcomes Workgroup, the usage of electronic nicotine delivery systems, commonly known as "e-cigarettes," is alarmingly high among Guam's teenagers. Approximately one in four high school students, or 26.5%, and approximately one in four middle school students, or 23.5%, reported current usage of e-cigarettes.

 

Senator Perez expressed that these data are shocking. She stated that some studies have found that teenagers who smoke and are exposed to nicotine are more likely to become addicted, which can harm their cognitive development. Furthermore, addiction during adolescence is also more difficult to overcome.

 

Senator Perez stated that tobacco-related diseases are currently the leading cause of death in Guam, and tobacco control policies are closely associated with reducing smoking and smokeless tobacco use. She emphasized the need for a comprehensive approach to control the spread of tobacco and nicotine products, enhance youth defense mechanisms, raise their health awareness, and promote a more active lifestyle.

 

Senator Perez mentioned that the passage of bills 186, 187, 194, and 185 will strengthen tobacco control laws, prevent youth access to tobacco and nicotine products, and allocate more resources towards education, prevention, cessation, and enforcement efforts.

 

Bill 194-37 requires any retailer selling tobacco and nicotine products to undergo training before obtaining a license.

 

The bill will increase fines and license suspensions for the sale of products without a permit. For first-time offenders, fines will be raised to $5,000. For second-time offenders, fines will be increased to $10,000 and the offender will be ineligible for a permit for two years following the fine. For third-time offenders, fines will be raised to $20,000. Additionally, according to the bill, there will be an increase in funding and enforcement for tobacco and nicotine education and prevention programs.

 

Bill No. 187-37 will prohibit the sale of tobacco or e-cigarette products in Guam through vending machines. Meanwhile, Bill No. 195-37 aims to restrict the advertising of tobacco products or e-cigarettes.

 

Indirect advertisements for various tobacco products still remain widespread in retail stores, shop windows, and parking lots. This bill aims to prohibit the advertising of tobacco products or e-cigarettes through various media such as television, radio, print, as well as within 6 feet of retail points.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

JUUL2 Sued Within a Week of FDA Authorization as AJ Marketing Alleges Infringement of Programmable Vape Patent
JUUL2 Sued Within a Week of FDA Authorization as AJ Marketing Alleges Infringement of Programmable Vape Patent
Less than a week after JUUL2 received U.S. FDA marketing authorization on August 28, 2026, JUUL Labs was sued for patent infringement in federal court in Delaware. AJ Marketing LLC filed the complaint on September 3, alleging that both JUUL 1 and JUUL2 infringe U.S. Patent No. 8,851,068 B2. The patent covers aspects of programmable electronic vaporization devices, including controls over dose delivery, usage frequency and operating parameters. The plaintiff is seeking reasonable royalties and ongoing royalties tied to the remaining life of the patent. JUUL has not yet publicly responded to the case.
Sep.10
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Eleftheria (Ria) Kioupritzi, a biopharmaceutical professional with more than 15 years of experience, has joined Philip Morris International as Director Scientific Affairs within Corporate Affairs. She previously served at Roche as Senior Scientific Communications Director for Neuroscience and Rare Diseases and worked extensively in spinal muscular atrophy. Her earlier career also covered competitive intelligence, clinical and regulatory monitoring, pipeline development and launch preparation. During her time working in Roche's SMA field, Evrysdi passed through several U.S. FDA milestones, including its initial approval, an expanded indication for younger infants and approval of a tablet formulation. Public records do not show that Kioupritzi herself led the FDA submissions.
Sep.22
FDA Authorizes JUUL2, Cites Adult Switching Amid Efforts to Speed PMTA Reviews
FDA Authorizes JUUL2, Cites Adult Switching Amid Efforts to Speed PMTA Reviews
The FDA authorized the JUUL2 device and tobacco- and menthol-flavored pods on Aug. 28, bringing the number of authorized e-cigarette products to 48. The agency highlighted complete switching among adult smokers, with six-week switching rates reaching 28.4%–49.3% for the menthol pod. The decision comes as FDA works to speed PMTA reviews, reduce application backlogs and expand authorized e-cigarette and nicotine-pouch products while maintaining enforcement priorities for unauthorized products.
Regulations
Aug.29
Imperial Brands Acquires Helwit Owner Yoik Group for SEK 515 Million, More Than Doubling Swedish Nicotine Pouch Share
Imperial Brands Acquires Helwit Owner Yoik Group for SEK 515 Million, More Than Doubling Swedish Nicotine Pouch Share
Imperial Brands has agreed to acquire 100% of Swedish modern oral nicotine company Yoik Group AB for an initial SEK515 million, equivalent to about US$53.9 million, plus a deferred payment linked to performance over the next two years. Yoik owns nicotine pouch brand Helwit, which held about 3.4% of Sweden’s modern oral nicotine market over the past 12 months. Imperial says the acquisition will more than double its existing share of the Swedish market. Helwit is also sold elsewhere in the Nordics, through European online channels and in selected UK retail outlets.
Sep.08
Australia Adds 6-Methylnicotine to Schedule 9 Prohibited Substances, Effective October 1
Australia Adds 6-Methylnicotine to Schedule 9 Prohibited Substances, Effective October 1
Australia's Therapeutic Goods Administration published a final decision on September 25 to classify 6-methylnicotine as a Schedule 9 prohibited substance under the Poisons Standard, effective October 1, 2026. TGA said the chemical has been reported in e-cigarette liquids sold in Australia and marketed as nicotine-free or nicotine alternatives, while evidence also indicates its use in preparations such as oral pouches. The government originally proposed a Schedule 7 classification but ultimately adopted the stricter Schedule 9 designation, citing acute toxicity, dependence risk, use in unapproved consumer products and misleading marketing.
News
Sep.29 by 2Firsts Perspectives
Philippines BIR Steps Up Illicit Vape Enforcement Ahead of Christmas Shopping
Philippines BIR Steps Up Illicit Vape Enforcement Ahead of Christmas Shopping
The Philippines’ Bureau of Internal Revenue is intensifying enforcement against illicit vape and tobacco products ahead of the Christmas shopping season, directing regional and enforcement offices to strengthen monitoring of production sites, warehouses, distribution channels and retail outlets. The BIR destroyed 240,550 illicit vape products in August with an estimated tax liability of about PHP1.53 billion. A nationwide tax-compliance operation in July also inspected 3,590 businesses involved in tobacco and vapor products.
Regulations
Sep.17 by 2Firsts Perspectives